Metronidazole
Trichomoniasis, Amebiasis, Anaerobic Bacterial Infections
Boxed warning
- WARNING Metronidazole has been shown to be carcinogenic in mice and rats (see PRECAUTIONS ). Unnecessary use of the drug should be avoided. Its use should be reserved for the conditions described in the INDICATIONS AND USAGE section below.
Indications
- Trichomoniasis
- Amebiasis
- Anaerobic Bacterial Infections
Adult dosing
- trichomoniasis 1day: dose: 2; unit: g; route: PO; interval: single dose or two divided doses in same day; fixed: true; labelExcerpt: One-day treatment − two grams of metronidazole tablets, given either as a single dose or in two divided doses of one gram each, given in the same day.
- trichomoniasis 7day: dose: 250; unit: mg; route: PO; interval: three times daily for seven days; fixed: true; labelExcerpt: Seven-day course of treatment − 250 mg three times daily for seven consecutive days.
- amebiasis: dose: 750; unit: mg; route: PO; interval: three times daily for 5 to 10 days; fixed: true; labelExcerpt: 750 mg orally three times daily for 5 to 10 days.
- anaerobic infections: dose: 7.5; unit: mg/kg; route: PO; interval: every six hours; weightBased: true; labelExcerpt: The usual adult oral dosage is 7.5 mg/kg every six hours (approx. 500 mg for a 70-kg adult). A maximum of 4 g should not be exceeded during a 24-hour period.
Pediatric dosing
- amebiasis: dose: 35; unit: mg/kg/day; route: PO; interval: divided into three doses, for 10 days; weightBased: false; pedNote: No label-stated per-dose maximum verified; weight-based calculation disabled. Consult pharmacy/current label.; labelExcerpt: Pediatric patients : 35 to 50 mg/kg/24 hours, divided into three doses, orally for 10 days.
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- Reduce dose by 50% in patients with severe (Child-Pugh C) impairment.
Contraindications
- Hypersensitivity to metronidazole
- First trimester of pregnancy (trichomoniasis)
- Use of disulfiram within 2 weeks
- Cockayne syndrome
Clinical pearls
- Avoid alcohol during and for 3 days after therapy due to disulfiram-like reaction.
- Monitor for CNS adverse effects like seizures and peripheral neuropathy.
- Severe cutaneous adverse reactions (SCARs) may occur; discontinue if symptoms develop.
- Supplement dose after hemodialysis session.
Source and review
- DailyMed label (metronidazole), Set ID 2f7d84d4-1085-4243-be88-442eecb85205, effective 2026-11-06. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties